Requires the registration of chain and community pharmacies
This bill would amend the New York Education Law to create a new registration system for “chain pharmacies” and “community pharmacies.” It defines a chain pharmacy as a publicly traded company with at least 20 licensed pharmacies in New York under common ownership, and a community pharmacy as a privately held company with fewer than 20 licensed pharmacies in New York under common ownership. The bill also excludes several types of pharmacies from the community pharmacy category, including government-owned, hospital-owned, supermarket or general merchandise store pharmacies, medical practice or clinic extensions, out-of-state corporate chains, mail-order pharmacies, and pharmacies owned by pharmacy benefit managers or health insurers.
Under the bill, each chain or community pharmacy would have to apply to the Department of Education for a designation as either a chain or community pharmacy, using a form prescribed by the department. That designation would need to be renewed every three years, and each application would require a $500 fee. The bill would take effect 90 days after becoming law, with immediate authorization for any necessary implementing regulations.
The bill’s main impact would be to add a new regulatory and administrative layer to pharmacy oversight in New York. It would require affected pharmacy owners to identify themselves to the state, pay a fee, and periodically renew their status, while giving the state a clearer way to track pharmacy ownership structures and distinguish large publicly traded chains from smaller privately held pharmacies. The measure would affect pharmacy operators, the Department of Education, and potentially related health care entities that own or control pharmacies.
Because the bill was only introduced and referred to the Assembly Committee on Higher Education, there is no recorded vote or committee transcript to show formal support or opposition. Based on the text alone, the bill appears aimed at increasing transparency and regulatory oversight of pharmacy ownership, but the absence of hearing records means the broader sentiment is not documented in the available materials.
No specific points of contention are recorded in the provided history, but the definitions and exclusions could be debated. In particular, the distinctions among chain pharmacies, community pharmacies, and excluded entities such as supermarket pharmacies, hospital pharmacies, mail-order pharmacies, and PBM- or insurer-owned pharmacies may raise questions about scope, fairness, and administrative burden. The $500 fee and three-year renewal requirement could also be viewed as burdensome by smaller pharmacy operators or as a modest regulatory cost by supporters.
The bill would amend Section 6808 of the Education Law to establish a new registration and designation process for chain and community pharmacies in New York. It would require covered pharmacies to apply to the Department of Education, renew their designation every three years, and pay a $500 fee, thereby creating new compliance obligations for pharmacy owners and new administrative responsibilities for the state. It would also formalize statutory definitions that distinguish large publicly traded pharmacy chains from smaller privately held community pharmacies and exclude several categories of pharmacies from the community pharmacy definition.
There is no recorded committee debate or vote in the provided materials, so no formal sentiment can be measured from legislative action. The bill’s text suggests a policy goal of greater oversight and transparency in pharmacy ownership, which may appeal to supporters of pharmacy regulation, but the available record does not show whether lawmakers, industry stakeholders, or the public viewed it favorably or opposed it. As introduced and referred to committee, the bill appears to be in an early stage without documented consensus or controversy in the supplied history.
No specific contention is documented in the provided transcripts or votes, but the bill’s definitions are likely to be the main area of dispute. Potential concerns include whether the 20-pharmacy threshold appropriately captures chain pharmacies, whether the exclusions for supermarkets, hospitals, mail-order pharmacies, PBM-owned pharmacies, and out-of-state chains are justified, and whether the $500 fee and triennial renewal impose unnecessary burdens. Pharmacy operators, pharmacy benefit managers, health insurers, and possibly hospital or supermarket pharmacy interests would be the most likely stakeholders to raise concerns or support depending on how the registration system affects them.